Form D — AN2 Therapeutics, Inc.
0001880438-26-000001 · filed Mar 25, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $39,999,989
- Total sold
- $39,999,989
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- AN2 Therapeutics, Inc.
- CIK
- 1880438
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA 94025 - Phone
- (650) 331-9090
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Eric Easom · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
-
Joshua Eizen · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
-
Lucy Day · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
-
Sanjay Chanda · Executive OfficerMENLO PARK, CA Find on LinkedIn ↗
-
Joseph S. Zakrzewski · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Kabeer Aziz · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Rob Readnour · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Gilbert Lynn Marks · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Stephanie Wong · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Patricia Martin · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Melvin Spigelman · DirectorMENLO PARK, CA Find on LinkedIn ↗
-
Margaret FitzPatrick · DirectorMENLO PARK, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗